BAXTER INTERNATIONAL INC (BAX) Stock Price, Quote, News and Overview
NYSE:BAX - New York Stock Exchange, Inc. - US0718131099 - Common Stock - Currency: USD
BAX Quote, Performance and Key Statistics
BAXTER INTERNATIONAL INC
NYSE:BAX (2/5/2025, 8:04:00 PM)
After market: 31.5 +0.03 (+0.1%)31.47
+0.05 (+0.16%)
The current stock price of BAX is 31.47 USD. In the past month the price increased by 6.1%. In the past year, price decreased by -20.43%.
BAX Latest News, Press Releases and Analysis
Baxter Announces CEO Retirement and Appointment of COO
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company
/PRNewswire-HISPANIC PR WIRE/ -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the...
La división de Cuidado Renal de Baxter ahora es Vantive, una nueva compañÃa independiente de terapias para órganos vitales
/PRNewswire-HISPANIC PR WIRE/ -- Vantive, que anteriormente formaba parte de la división de cuidado renal de Baxter, inicia hoy su camino como una nueva...
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company
Confidence Is Just As Dangerous When It's Too Low As When It's Too High
To attain goals, you need confidence. It takes self-assurance to pursue what matters most to you. But too much confidence has risks, too.
BAX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.28 | 229.05B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.61 | 210.47B | ||
| BSX | BOSTON SCIENTIFIC CORP | 44.48 | 154.71B | ||
| SYK | STRYKER CORP | 32.74 | 152.14B | ||
| MDT | MEDTRONIC PLC | 17.46 | 117.57B | ||
| BDX | BECTON DICKINSON AND CO | 18.62 | 71.07B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27 | 42.52B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.66 | 39.83B | ||
| IDXX | IDEXX LABORATORIES INC | 41.65 | 38.36B | ||
| RMD | RESMED INC | 27.44 | 35.61B | ||
| DXCM | DEXCOM INC | 52.22 | 34.68B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.62 | 25.78B |
Related stock screener links
About BAX
Company Profile
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 60,000 full-time employees. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.
Company Info
BAXTER INTERNATIONAL INC
1 Baxter Parkway,
Deerfield ILLINOIS 60015 US
CEO: Jose E. Almeida
Employees: 60000
Company Website: https://www.baxter.com/
Investor Relations: https://investor.baxter.com
Phone: 18442945418
BAX FAQ
What is the stock price of BAX?
The current stock price of BAX is 31.47 USD.
What is the symbol for BAXTER INTERNATIONAL INC stock?
The exchange symbol of BAXTER INTERNATIONAL INC is BAX and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is BAX stock listed?
BAX stock is listed on the New York Stock Exchange, Inc. exchange.
Is BAX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for BAX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of BAX.
Does BAX stock pay dividends?
BAX has a dividend yield of 2.05%. The yearly dividend amount is currently 1.16.
When does BAX stock report earnings?
BAX will report earnings on 2025-02-13, after the market close.
What is the Price/Earnings (PE) ratio of BAX?
The PE ratio for BAX is 10.46. This is based on the reported non-GAAP earnings per share of 3.01 and the current share price of 31.47 USD.
What is the Short Interest ratio of BAX stock?
The outstanding short interest for BAX is 3.3% of its float.
BAX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BAX. When comparing the yearly performance of all stocks, BAX is a bad performer in the overall market: 83.18% of all stocks are doing better.
BAX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BAX. Both the profitability and the financial health of BAX get a neutral evaluation. Nothing too spectacular is happening here.
BAX Financial Highlights
Over the last trailing twelve months BAX reported a non-GAAP Earnings per Share(EPS) of 3.01. The EPS increased by 11.48% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.77% | ||
| ROA | 0.4% | ||
| ROE | 1.37% | ||
| Debt/Equity | 1.33 |
BAX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 56% to BAX. The Buy consensus is the average rating of analysts ratings from 23 analysts.
For the next year, analysts expect an EPS growth of -31.57% and a revenue growth -28.38% for BAX